# Study To Assess Efficacy, Safety, Tolerability And Pharmacokinetics Of PF-07038124 Ointment In Participants With Atopic Dermatitis Or Plaque Psoriasis

> **NCT04664153** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 104 (actual)

## Conditions studied

- Atopic Dermatitis
- Plaque Psoriasis

## Interventions

- **DRUG:** PF-07038124 ointment
- **DRUG:** Vehicle ointment

## Key facts

- **NCT ID:** NCT04664153
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-21
- **Primary completion:** 2021-08-18
- **Final completion:** 2021-08-18
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2022-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04664153

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04664153, "Study To Assess Efficacy, Safety, Tolerability And Pharmacokinetics Of PF-07038124 Ointment In Participants With Atopic Dermatitis Or Plaque Psoriasis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04664153. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*